Patent · US Active

Methods and compositions for treatment of retinal degeneration

US9326999B2 · kind B2 · utility

7Cited by
6References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2013
Grant dateMay 3, 2016
Priority date
Expiry dateMar 13, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2035/124
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for treating retinal degeneration, such as occurs in retinitis pigmentosa and age-related macular degeneration, using descendents of marrow adherent stem cells that have been engineered to express an exogenous Notch intracellular domain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.